Cti Biopharma reported $77.49M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Applied Genetic Technologies AGTC:US $ 126.97M 2.7M
Baxter International BAX:US $ 19682M 216M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Cti Biopharma CTIC:US $ 77.5M 34.71M
Cytori Therapeutics CYTX:US $ 20.83M 2.5M
Eli Lilly And LLY:US $ 47809M 970.7M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Northwest Biotherapeutics NWBO:US 28.77M 3.69M
Novartis NOVN:VX SF 124015M 2263M
Novartis NVS:US $ 124015M 2263M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Sunesis Pharmaceuticals SNSS:US $ 128.68M 7.53M
Teva Pharmaceutical Industries TEVA:US $ 49195M 191M
YTE INCY:US $ 3904.62M 243.19M